Antimicrobial resistance (AMR) is perhaps the most pressing global health crisis of our time. The pipeline for new antibiotics is slow, meaning that our most powerful tool in the fight against “superbugs” is optimizing the use of the drugs we already possess. The traditional approach to antibiotic dosing—relying on standard, one-size-fits-all nomograms—is increasingly inadequate because […]

𝐇𝐞𝐚𝐝𝐥𝐢𝐧𝐞: 𝐍𝐚𝐯𝐢𝐠𝐚𝐭𝐢𝐧𝐠 𝐀𝐈 𝐑𝐢𝐬𝐤 𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞: 𝐈𝐭 𝐒𝐭𝐚𝐫𝐭𝐬 𝐰𝐢𝐭𝐡 𝐚 𝐅𝐫𝐚𝐦𝐞𝐰𝐨𝐫𝐤 𝐀𝐈 𝐚𝐧𝐝 𝐌𝐚𝐜𝐡𝐢𝐧𝐞 𝐋𝐞𝐚𝐫𝐧𝐢𝐧𝐠 𝐚𝐫𝐞 𝐭𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦𝐢𝐧𝐠 𝐦𝐞𝐝𝐢𝐜𝐚𝐥 𝐝𝐞𝐯𝐢𝐜𝐞𝐬, 𝐨𝐟𝐟𝐞𝐫𝐢𝐧𝐠 𝐢𝐧𝐜𝐫𝐞𝐝𝐢𝐛𝐥𝐞 𝐩𝐨𝐭𝐞𝐧𝐭𝐢𝐚𝐥 𝐟𝐨𝐫 𝐝𝐢𝐚𝐠𝐧𝐨𝐬𝐢𝐬, 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭, 𝐚𝐧𝐝 𝐩𝐚𝐭𝐢𝐞𝐧𝐭 𝐜𝐚𝐫𝐞. 𝐁𝐮𝐭 𝐰𝐢𝐭𝐡 𝐭𝐡𝐢𝐬 𝐩𝐨𝐰𝐞𝐫 𝐜𝐨𝐦𝐞𝐬 𝐚 𝐜𝐫𝐢𝐭𝐢𝐜𝐚𝐥 𝐪𝐮𝐞𝐬𝐭𝐢𝐨𝐧: 𝐇𝐨𝐰 𝐝𝐨 𝐰𝐞 𝐞𝐧𝐬𝐮𝐫𝐞 𝐭𝐡𝐞𝐬𝐞 “𝐛𝐥𝐚𝐜𝐤 𝐛𝐨𝐱” 𝐬𝐲𝐬𝐭𝐞𝐦𝐬 𝐚𝐫𝐞 𝐬𝐚𝐟𝐞 𝐚𝐧𝐝 𝐞𝐟𝐟𝐞𝐜𝐭𝐢𝐯𝐞? 𝐄𝐧𝐭𝐞𝐫 𝐀𝐀𝐌𝐈 𝐓𝐈𝐑𝟑𝟒𝟗𝟕𝟏. 𝐓𝐡𝐢𝐬 𝐓𝐞𝐜𝐡𝐧𝐢𝐜𝐚𝐥 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 𝐑𝐞𝐩𝐨𝐫𝐭 […]

The pharmaceutical landscape is being rapidly reshaped by a class of drugs known as incretin mimetics, particularly the new generation of anti-obesity medications (AOMs). While the public focuses on the dramatic weight loss achieved by agonists like semaglutide and tirzepatide, the true marvel of these therapeutics lies in their precise Pharmacokinetics (PK) and Pharmacodynamics (PD). These […]

𝐈𝐧 𝐓𝐞𝐧𝐧𝐞𝐬𝐬𝐞𝐞, 𝟏 𝐢𝐧 𝟒 𝐩𝐞𝐨𝐩𝐥𝐞 𝐡𝐚𝐬 𝐦𝐞𝐝𝐢𝐜𝐚𝐥 𝐝𝐞𝐛𝐭 𝐢𝐧 𝐜𝐨𝐥𝐥𝐞𝐜𝐭𝐢𝐨𝐧𝐬. 𝐓𝐡𝐚𝐭’𝐬 𝐧𝐨𝐭 𝐣𝐮𝐬𝐭 𝐚 𝐡𝐞𝐚𝐥𝐭𝐡 𝐬𝐭𝐚𝐭𝐢𝐬𝐭𝐢𝐜—𝐢𝐭’𝐬 𝐚 𝐩𝐨𝐰𝐞𝐫𝐟𝐮𝐥 𝐞𝐜𝐨𝐧𝐨𝐦𝐢𝐜 𝐢𝐧𝐝𝐢𝐜𝐚𝐭𝐨𝐫. 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐝𝐞𝐛𝐭 𝐝𝐨𝐞𝐬𝐧’𝐭 𝐣𝐮𝐬𝐭 𝐫𝐞𝐟𝐥𝐞𝐜𝐭 𝐚𝐧 𝐢𝐥𝐥𝐧𝐞𝐬𝐬 𝐨𝐫 𝐢𝐧𝐣𝐮𝐫𝐲; 𝐢𝐭 𝐫𝐞𝐟𝐥𝐞𝐜𝐭𝐬 𝐚 𝐬𝐲𝐬𝐭𝐞𝐦 𝐭𝐡𝐚𝐭 𝐭𝐫𝐞𝐚𝐭𝐬 𝐡𝐮𝐦𝐚𝐧 𝐡𝐞𝐚𝐥𝐭𝐡 𝐚𝐬 𝐚 𝐬𝐨𝐮𝐫𝐜𝐞 𝐨𝐟 𝐫𝐞𝐯𝐞𝐧𝐮𝐞, 𝐥𝐞𝐚𝐯𝐢𝐧𝐠 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬 𝐟𝐢𝐧𝐚𝐧𝐜𝐢𝐚𝐥𝐥𝐲 𝐩𝐨𝐰𝐞𝐫𝐥𝐞𝐬𝐬. 𝐓𝐡𝐞 𝐡𝐮𝐦𝐚𝐧 𝐜𝐨𝐬𝐭 𝐢𝐬 𝐩𝐫𝐨𝐟𝐨𝐮𝐧𝐝: 𝐃𝐫𝐚𝐢𝐧𝐞𝐝 𝐬𝐚𝐯𝐢𝐧𝐠𝐬 𝐚𝐧𝐝 […]

A new era in Alzheimer’s diagnosis began this year. The FDA granted clearance to two blood biomarker tests for Alzheimer’s disease, moving them from the category of Laboratory Developed Tests (LDTs) to In Vitro Diagnostic (IVD) devices. This transition isn’t just regulatory paperwork; it’s a critical evolution in making advanced diagnostics more accessible and standardized […]

𝗡𝗼 𝘀𝘂𝗿𝗽𝗿𝗶𝘀𝗲: 𝗜 𝘀𝘂𝗽𝗽𝗼𝗿𝘁 𝗨𝗻𝗶𝘃𝗲𝗿𝘀𝗮𝗹 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗮𝘀 𝗮𝗹𝗹 𝘁𝗵𝗲 𝗺𝗼𝗱𝗲𝗿𝗻 𝗶𝗻𝗱𝘂𝘀𝘁𝗿𝗶𝗮𝗹𝗶𝘇𝗲𝗱 𝗰𝗼𝘂𝗻𝘁𝗿𝗶𝗲𝘀 𝗼𝗳 𝘁𝗵𝗲 𝘄𝗼𝗿𝗹𝗱 𝗵𝗮𝘀, 𝗘𝗫𝗖𝗘𝗣𝗧 𝘁𝗵𝗲 𝗨𝗦𝗔. 𝗜 𝗸𝗻𝗼𝘄 𝗽𝗲𝗼𝗽𝗹𝗲 𝘄𝗵𝗼 𝗱𝗶𝗲𝗱 𝗶𝗻 𝘁𝗵𝗲 𝗽𝗮𝘀𝘁 𝗳𝗿𝗼𝗺 𝗹𝗮𝗰𝗸 𝗼𝗳 𝗵𝗲𝗮𝗹𝘁𝗵 𝗶𝗻𝘀𝘂𝗿𝗮𝗻𝗰𝗲, 𝗮𝗻𝗱 𝗜 𝘄𝗶𝗹𝗹 𝗸𝗻𝗼𝘄 𝗺𝗼𝗿𝗲 𝗶𝗻 𝘁𝗵𝗲 𝗳𝘂𝘁𝘂𝗿𝗲. 𝗙𝗿𝗼𝗺 𝗥𝗲𝗳𝗲𝗿𝗲𝗲 𝘁𝗼 𝗕𝘂𝗶𝗹𝗱𝗲𝗿: 𝗥𝗲𝗶𝗺𝗮𝗴𝗶𝗻𝗶𝗻𝗴 𝗘𝗰𝗼𝗻𝗼𝗺𝗶𝗰 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝘆 𝗧𝗵𝗲𝗿𝗲’𝘀 𝗮 𝗽𝗿𝗲𝘃𝗮𝗶𝗹𝗶𝗻𝗴 𝗺𝗼𝗱𝗲𝗹 𝗼𝗳 𝗴𝗼𝘃𝗲𝗿𝗻𝗺𝗲𝗻𝘁 𝗮𝘀 𝗮 […]

𝐈 𝐥𝐢𝐯𝐞 𝐢𝐧 𝐓𝐞𝐧𝐧𝐞𝐬𝐬𝐞𝐞 𝐚𝐧𝐝 𝐡𝐚𝐯𝐞 𝐫𝐞𝐜𝐞𝐢𝐯𝐞𝐝 𝐞𝐥𝐞𝐜𝐭𝐫𝐢𝐜𝐢𝐭𝐲 𝐠𝐞𝐧𝐞𝐫𝐚𝐭𝐞𝐝 𝐛𝐲 𝐓𝐕𝐀 𝐦𝐨𝐬𝐭 𝐨𝐟 𝐦𝐲 𝐥𝐢𝐟𝐞. 𝐀𝐦 𝐈 𝐰𝐨𝐫𝐫𝐢𝐞𝐝 𝐭𝐡𝐚𝐭 𝐬𝐨𝐦𝐞 𝐢𝐠𝐧𝐨𝐫𝐚𝐧𝐭 𝐩𝐞𝐨𝐩𝐥𝐞 𝐭𝐡𝐢𝐧𝐤 𝐓𝐕𝐀 𝐢𝐬 𝐬𝐨𝐜𝐢𝐚𝐥𝐢𝐬𝐦? 𝐍𝐨! 𝐍𝐨𝐭 𝐚𝐭 𝐚𝐥𝐥! It is a fantastic example of socialism for the benefit of all.  𝐀 𝐇𝐢𝐬𝐭𝐨𝐫𝐲 𝐋𝐞𝐬𝐬𝐨𝐧 𝐢𝐧 𝐄𝐜𝐨𝐧𝐨𝐦𝐢𝐜 𝐁𝐮𝐢𝐥𝐝𝐢𝐧𝐠: 𝐓𝐡𝐞 𝐓𝐕𝐀 𝐌𝐨𝐝𝐞𝐥 𝐃𝐢𝐬𝐜𝐮𝐬𝐬𝐢𝐨𝐧𝐬 𝐚𝐛𝐨𝐮𝐭 𝐚𝐟𝐟𝐨𝐫𝐝𝐚𝐛𝐢𝐥𝐢𝐭𝐲 𝐨𝐟𝐭𝐞𝐧 […]

🚨 New Interventional Cardiology Trial Alert: PROCTOR Study Results In patients with prior CABG and failing saphenous vein grafts (SVGs), the choice of which vessel to re-intervene on is a common dilemma. The just-published PROCTOR trial provides compelling evidence. ➡ The Study: Randomized 220 post-CABG patients with SVG failure to receive PCI either on the native coronary artery (108 pts) or on […]

𝐓𝐡𝐞 𝐚𝐫𝐭𝐢𝐜𝐥𝐞 𝐛𝐞𝐥𝐨𝐰 𝐦𝐞𝐧𝐭𝐢𝐨𝐧𝐬 𝐚 𝐬𝐭𝐮𝐝𝐲 𝐭𝐡𝐚𝐭 𝐢𝐬 “𝐩𝐨𝐬𝐢𝐭𝐢𝐯𝐞” 𝐢𝐧 𝐭𝐡𝐞 𝐬𝐞𝐧𝐬𝐞 𝐭𝐲𝐩𝐢𝐜𝐚𝐥𝐥𝐲 𝐟𝐨𝐮𝐧𝐝 𝐢𝐧 𝐭𝐡𝐞 𝐩𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲: 𝐦𝐞𝐝𝐢𝐚𝐧 𝐨𝐯𝐞𝐫𝐚𝐥𝐥 𝐬𝐮𝐫𝐯𝐢𝐯𝐚𝐥 𝐢𝐧𝐜𝐫𝐞𝐚𝐬𝐞𝐝 𝐟𝐫𝐨𝐦 𝟖 𝐦𝐨𝐧𝐭𝐡𝐬 𝐭𝐨 𝟏𝟔 𝐦𝐨𝐧𝐭𝐡𝐬. 𝐓𝐡𝐚𝐭 𝐢𝐬 𝐧𝐨𝐭 𝐚 𝐩𝐨𝐬𝐢𝐭𝐢𝐯𝐞 𝐞𝐧𝐨𝐮𝐠𝐡 𝐫𝐞𝐬𝐮𝐥𝐭 𝐭𝐡𝐚𝐭 𝐈 𝐰𝐨𝐮𝐥𝐝 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐰𝐢𝐭𝐡 𝐈𝐕 𝐕𝐢𝐭𝐚𝐦𝐢𝐧 𝐂, 𝐛𝐮𝐭 𝐢𝐭 𝐫𝐞𝐟𝐥𝐞𝐜𝐭𝐬 𝐭𝐡𝐞 𝐚𝐝𝐯𝐚𝐧𝐜𝐞𝐝 𝐬𝐭𝐚𝐠𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐜𝐚𝐧𝐜𝐞𝐫 𝐚𝐧𝐝 𝐭𝐡𝐞 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬’ […]